HCAT Q3 2025 Earnings Call Summary | Stock Taper
Logo
HCAT

HCAT — Health Catalyst, Inc.

NASDAQ


Q3 2025 Earnings Call Summary

November 10, 2025

Health Catalyst (HCAT) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

  • Total Revenue: $76.3 million, flat year-over-year, exceeding guidance.
  • Technology Segment Revenue: $52.1 million, a 7% increase year-over-year.
  • Adjusted EBITDA: $12 million, surpassing guidance of $10.5 million and up 64% from Q3 2024.
  • Adjusted Gross Margin: 53%, a 50 basis point improvement year-over-year.
  • Professional Services Revenue: $24.3 million, a 12% decline year-over-year due to exiting less profitable contracts.
  • Cash Position: $92 million at the end of Q3 2025, down from $392 million at year-end 2024.

2. Strategic Updates and Business Highlights

  • Client Additions: Anticipating approximately 30 net new platform client additions for 2025, with average booking sizes expected at the lower end of the $300,000 to $700,000 range.
  • Leadership Changes: Strengthening of the leadership team with key appointments to support operational and strategic goals.
  • Operational Efficiency: Initiatives to streamline operations and enhance client services, including successful case studies showcasing significant cost savings for clients.
  • Ignite Migration: Progress on migrating clients from the DOS platform to Ignite, with approximately two-thirds expected to migrate by the end of 2025.

3. Forward Guidance and Outlook

  • 2025 Full-Year Guidance: Revenue expected to be approximately $310 million (1% year-over-year growth) and adjusted EBITDA of $41 million (57% year-over-year growth).
  • Q4 2025 Expectations: Slight decline in technology revenue due to migration-related churn, while professional services revenue is also expected to decrease.
  • 2026 Outlook: Anticipating revenue performance to be a few points lower than 2025, driven by dollar-based retention pressures and lower net new client counts.

4. Bad News, Challenges, or Points of Concern

  • Dollar-Based Retention: Expected to be in the low 90s for 2025, indicating pressure on existing client relationships during the migration process.
  • Professional Services Decline: Continued exit from less profitable contracts is impacting revenue, with a focus on improving profitability.
  • Market Dynamics: Clients are facing budget constraints, impacting their willingness to migrate to Ignite and invest in new technology.
  • Competitive Pressures: Clients are prioritizing cost management and operational efficiency, which may affect spending on new technology solutions.

5. Notable Q&A Insights

  • Ignite Migration Timeline: Management acknowledged that some clients prefer to remain on DOS longer due to existing value, leading to a more flexible migration approach. They anticipate a large majority of clients to migrate by 2026.
  • Revenue Model Considerations: Discussions around potentially introducing ROI guarantees for clients to enhance the value proposition of technology offerings.
  • Pipeline Robustness: Despite challenges, the pipeline remains strong with expectations for smaller deal sizes moving through more quickly.
  • AI Integration: Emphasis on leveraging AI capabilities to enhance existing solutions and drive value for clients, with ongoing investments in this area.

This summary encapsulates the key elements from the earnings call, highlighting both the positive developments and the challenges faced by Health Catalyst as they navigate their strategic initiatives and market conditions.